Cart
sales@molnova.com
(Tyr38,Phe42·46)-Osteocalcin (38-49) (human)
CAS No. 129356-77-0
(Tyr38,Phe42·46)-Osteocalcin (38-49) (human)( ——— )
Catalog No. M40061 CAS No. 129356-77-0
YQEAFRRFFGPV is a short peptide sequence containing 12 amino acid residues with some emulsification ability
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(Tyr38,Phe42·46)-Osteocalcin (38-49) (human)
-
NoteResearch use only, not for human use.
-
Brief DescriptionYQEAFRRFFGPV is a short peptide sequence containing 12 amino acid residues with some emulsification ability
-
DescriptionYQEAFRRFFGPV is a short peptide sequence containing 12 amino acid residues with some emulsification ability
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number129356-77-0
-
Formula Weight1516.7
-
Molecular FormulaC73H101N19O17
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Shuryo Nakai, et al. Pattern similarity analysis of amino acid sequences for peptide emulsification. J Agric Food Chem. 2004 Feb 25;52(4):927-34.??
molnova catalog
related products
-
AR-M 1000390 hydroch...
AR-M 1000390 (hydrochloride), also known as ARM-390, is a low-internalizing nonpeptidic δ-selective opioid receptor agonist; derivative of SNC 80.
-
4,4'-Methylenediphen...
4,4'-Methylenediphenol is a high purity product from Gastrodia rhizome with antioxidant activities.
-
Letaplimab
Letaplimab (IBI-188) is a humanized IgG4 class antibody targeting CD47 and is often used in combination with azacitidine for the treatment of primary diagnosis of intermediate- to high-risk myelodysplastic syndromes.
